# OnCo record nct07718243 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07718243/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07718243", "NCT07718243" ;
  schema:name "Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC"@en ;
  schema:alternateName "BLAZE"@en ;
  schema:description "A phase 1/2 trial in lung cancer, run by Institute of Cancer Research, United Kingdom, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07718243/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07718243> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/faron-pharmaceuticals/> .